Rapamycin and its analogs, sirolimus, everolimus and temsirolimus, inhibit mTOR pathway and are anti-tumor drugs used for metastatic renal cell carcinoma, pancreatic neuroendocrine tumors and advanced breast cancer. The gene discussed is MTOR; the disease is neoplasm.